64 related articles for article (PubMed ID: 21381039)
1. Serum levels of vascular endothelial growth factor in gastric cancer patients.
Eroğlu A
J Surg Oncol; 2011 Aug; 104(2):222. PubMed ID: 21381039
[No Abstract] [Full Text] [Related]
2. Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.
Seo HY; Park JM; Park KH; Kim SJ; Oh SC; Kim BS; Kim YH; Kim JS
Jpn J Clin Oncol; 2010 Dec; 40(12):1147-53. PubMed ID: 20647232
[TBL] [Abstract][Full Text] [Related]
3. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
[TBL] [Abstract][Full Text] [Related]
4. The effects of growth hormone status on circulating levels of vascular growth factors.
Silha JV; Krsek M; Hana V; Marek J; Weiss V; Jezkova J; Rosicka M; Jarkovska Z; Murphy LJ
Clin Endocrinol (Oxf); 2005 Jul; 63(1):79-86. PubMed ID: 15963066
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy.
Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E
Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factors C and D in patients with oesophageal cancer.
Kozlowski M; Kowalczuk O; Milewski R; Chyczewski L; Niklinski J; Laudański J
Eur J Cardiothorac Surg; 2010 Sep; 38(3):260-7. PubMed ID: 20226684
[TBL] [Abstract][Full Text] [Related]
7. Relationships between local and systemic expression of interleukin-12 and plasma levels of vascular endothelial growth factor in patients with gastric cancer.
Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Shibao K; Tsurudome K; Hirata K; Sako T; Nagata N; Itoh H
Anticancer Res; 2004; 24(5C):3289-94. PubMed ID: 15515423
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic factors are elevated in overweight and obese individuals.
Silha JV; Krsek M; Sucharda P; Murphy LJ
Int J Obes (Lond); 2005 Nov; 29(11):1308-14. PubMed ID: 15953938
[TBL] [Abstract][Full Text] [Related]
9. Potential prognostic value of circulating levels of vascular endothelial growth factor-A in patients with gastric cancer.
Ding S; Lin S; Dong X; Yang X; Qu H; Huang S; Liu W; Zhou L; Liu D
In Vivo; 2005; 19(4):793-5. PubMed ID: 15999551
[TBL] [Abstract][Full Text] [Related]
10. Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients.
Gretschel S; Astrosini Ch; Vieth M; Jöns T; Tomov T; Höcker M; Schlag PM; Kemmner W
Eur J Surg Oncol; 2008 Jun; 34(6):642-7. PubMed ID: 18023552
[TBL] [Abstract][Full Text] [Related]
11. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
12. [Expression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancer].
Wang XL; Ai ZS; Fang JP; Tang RY; Chen XM
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):837-43. PubMed ID: 19173829
[TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
15. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
16. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
17. Effect of vascular endothelial growth factors A, C, and D in HIV-associated pre-eclampsia.
Shange GP; Moodley J; Naicker T
Hypertens Pregnancy; 2017 May; 36(2):196-203. PubMed ID: 28524736
[TBL] [Abstract][Full Text] [Related]
18. Circulating stromal cell derived factor-1alpha (SDF-1alpha) is predictive of distant metastasis in gastric carcinoma.
Woo IS; Hong SH; Byun JH; Kang JH; Jeon HM; Choi MG
Cancer Invest; 2008; 26(3):256-61. PubMed ID: 18317966
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
